|
1
|
Granzyme A signaling
|
Apoptosis and survival
|
6.81E-08
|
|
2
|
TGF, WNT and cytoskeletal remodeling
|
Cytoskeleton remodeling
|
2.68E-07
|
|
3
|
Antigen presentation by MHC class I
|
Immune response
|
3.65E-07
|
|
4
|
IGF-1 receptor signaling
|
Development
|
4.78E-06
|
|
5
|
Androgen Receptor nuclear signaling
|
Transcription
|
6.57E-06
|
|
6
|
Glucocorticoid receptor signaling
|
Development
|
1.01E-05
|
|
7
|
ATM/ATR regulation of G1/S checkpoint
|
DNA damage
|
1.34E-05
|
|
8
|
LRRK2 in neurons in Parkinson's disease
| |
1.77E-05
|
|
9
|
GM-CSF signaling
|
Development
|
1.94E-05
|
|
10
|
Endothelial cell contacts by junctional mechanisms
|
Cell adhesion
|
1.98E-05
|
|
11
|
Cytoskeleton remodeling
|
Cytoskeleton remodeling
|
2.64E-05
|
|
12
|
AKT signaling
|
Signal transduction
|
2.78E-05
|
|
13
|
Endoplasmic reticulum stress response pathway
|
Apoptosis and survival
|
3.48E-05
|
|
14
|
Role of Activin A in cell differentiation and proliferation
|
Development
|
9.27E-05
|
|
15
|
WNT signaling pathway. Part 2
|
Development
|
1.84E-04
|
|
16
|
WNT signaling pathway. Part 1. Degradation of beta-catenin in the absence WNT signaling
|
Development
|
1.92E-04
|
|
17
|
TGF-beta-dependent induction of EMT via SMADs
|
Development
|
2.03E-04
|
|
18
|
Mismatch repair
|
DNA damage
|
2.63E-04
|
